0
0
AZ, Merck's Lynparza wins FDA nod in prostate cancer subgroup following advisory committee vote - FiercePharma
6/1/23 at 3:23pm
Organization
FiercePharma
Author
FiercePharma
16 words
0
Comments
You are the first to view
https://www.fiercepharma.com/pharma/astrazeneca-mercks-lynparza-wins-fda-nod-prostate-cancer-subgroup-following-advisory
Create an account or login to join the discussion